In transgenic models of T2D, the cell cycle inhibitor p27 (a marker of senescence) increases in pancreatic β cells, and p27 deletion increased insulin secretion and islet mass through increased proliferation (Uchida et al., 2005). Here, INS is linked to type 2 diabetes mellitus.